TPRX1
geneOn this page
Also known as FLJ40321
Summary
TPRX1 (tetrapeptide repeat homeobox 1, HGNC:32174) is a protein-coding gene on chromosome 19q13.33, encoding Tetra-peptide repeat homeobox protein 1 (Q8N7U7). Transcription factor expressed after fertilization required for zygotic genome activation (ZGA), a critical event in early embryonic development during which the developmental control passes from maternally provided mRNAs to the expression of the zygotic genome after fertilizati….
Homeobox genes encode DNA-binding proteins, many of which are thought to be involved in early embryonic development. Homeobox genes encode a DNA-binding domain of 60 to 63 amino acids referred to as the homeodomain. This gene is a member of the TPRX homeobox gene family.
Source: NCBI Gene 284355 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 96 total
- MANE Select transcript:
NM_001397346
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:32174 |
| Approved symbol | TPRX1 |
| Name | tetrapeptide repeat homeobox 1 |
| Location | 19q13.33 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ40321 |
| Ensembl gene | ENSG00000178928 |
| Ensembl biotype | protein_coding |
| OMIM | 611166 |
| Entrez | 284355 |
Gene structure
Transcript identifiers
Ensembl transcripts: 3 — 3 protein_coding
ENST00000322175, ENST00000535759, ENST00000698655
RefSeq mRNA: 2 — MANE Select: NM_001397346
NM_001397346, NM_198479
CCDS: CCDS33066, CCDS92654
Canonical transcript exons
ENST00000698655 — 3 exons
| Exon | Start | End |
|---|---|---|
| ENSE00003974338 | 47803504 | 47803673 |
| ENSE00003974339 | 47801232 | 47802980 |
| ENSE00003974340 | 47804515 | 47804551 |
Expression profiles
Bgee: expression breadth tissue_specific, 8 present calls, max score 52.00.
Top tissues by expression
128 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 52.00 | gold quality |
| left testis | UBERON:0004533 | 45.45 | gold quality |
| right testis | UBERON:0004534 | 45.20 | gold quality |
| testis | UBERON:0000473 | 45.11 | gold quality |
| colonic epithelium | UBERON:0000397 | 37.20 | gold quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| bone marrow cell | CL:0002092 | 36.16 | gold quality |
| sural nerve | UBERON:0015488 | 35.87 | gold quality |
| ganglionic eminence | UBERON:0004023 | 35.49 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 33.38 | gold quality |
| muscle tissue | UBERON:0002385 | 32.20 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 32.15 | gold quality |
| bone marrow | UBERON:0002371 | 31.74 | gold quality |
| monocyte | CL:0000576 | 30.18 | gold quality |
| prefrontal cortex | UBERON:0000451 | 29.99 | gold quality |
| leukocyte | CL:0000738 | 29.95 | gold quality |
| stromal cell of endometrium | CL:0002255 | 29.87 | gold quality |
| urinary bladder | UBERON:0001255 | 29.71 | gold quality |
| vermiform appendix | UBERON:0001154 | 29.36 | gold quality |
| duodenum | UBERON:0002114 | 28.14 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 27.61 | gold quality |
| lymph node | UBERON:0000029 | 27.57 | gold quality |
| cerebellum | UBERON:0002037 | 27.28 | silver quality |
| cerebellar hemisphere | UBERON:0002245 | 27.19 | silver quality |
| cerebellar cortex | UBERON:0002129 | 27.12 | silver quality |
| tonsil | UBERON:0002372 | 27.05 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 26.94 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 26.89 | gold quality |
| myometrium | UBERON:0001296 | 26.81 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-GEOD-36552 | yes | 923.85 |
| E-ANND-3 | no | 1.14 |
Regulation
Is transcription factor: yes
JASPAR motifs
| Motif | Name | Family |
|---|---|---|
| MA2600.1 | TPRX1 | Paired-related HD |
JASPAR matrix evidence (PMIDs): PMID:39605530
miRNA regulators (miRDB)
34 targeting TPRX1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4262 | 100.00 | 73.26 | 3931 |
| HSA-MIR-1252-5P | 100.00 | 69.80 | 2774 |
| HSA-MIR-3646 | 100.00 | 73.56 | 5283 |
| HSA-MIR-181A-5P | 99.99 | 72.96 | 2995 |
| HSA-MIR-181B-5P | 99.99 | 72.97 | 2996 |
| HSA-MIR-181C-5P | 99.99 | 72.95 | 2996 |
| HSA-MIR-181D-5P | 99.99 | 73.04 | 2997 |
| HSA-MIR-607 | 99.97 | 73.62 | 5593 |
| HSA-MIR-4725-3P | 99.96 | 69.53 | 2520 |
| HSA-MIR-6780B-5P | 99.96 | 69.60 | 2562 |
| HSA-MIR-7-1-3P | 99.91 | 71.53 | 4384 |
| HSA-MIR-7-2-3P | 99.91 | 71.40 | 4394 |
| HSA-MIR-3671 | 99.90 | 73.04 | 3897 |
| HSA-MIR-6756-5P | 99.82 | 67.97 | 2466 |
| HSA-MIR-6766-5P | 99.68 | 67.70 | 2325 |
| HSA-MIR-466 | 99.67 | 70.85 | 2863 |
| HSA-MIR-3158-5P | 99.65 | 67.51 | 1763 |
| HSA-MIR-4441 | 99.49 | 66.56 | 3216 |
| HSA-MIR-3123 | 99.47 | 67.15 | 2693 |
| HSA-MIR-6507-5P | 99.36 | 70.46 | 2524 |
| HSA-MIR-4270 | 99.02 | 66.26 | 1987 |
| HSA-MIR-6769B-5P | 98.73 | 64.91 | 1092 |
| HSA-MIR-7977 | 98.65 | 66.18 | 2590 |
| HSA-MIR-6754-5P | 98.60 | 65.54 | 1627 |
| HSA-MIR-302F | 98.44 | 69.02 | 1776 |
| HSA-MIR-3155A | 98.16 | 66.09 | 965 |
| HSA-MIR-3155B | 98.16 | 66.09 | 965 |
| HSA-MIR-484 | 98.16 | 66.92 | 1074 |
| HSA-MIR-6881-5P | 98.16 | 67.38 | 665 |
| HSA-MIR-211-3P | 98.14 | 66.77 | 1052 |
Cross-species orthologs
0 orthologs
Paralogs (1): TPRX2 (ENSG00000259009)
Protein
Protein identifiers
Tetra-peptide repeat homeobox protein 1 — Q8N7U7 (reviewed: Q8N7U7)
All UniProt accessions (3): A0A8V8TM49, A0A8V8TMK4, D2CFI5
UniProt curated annotations — full annotation on UniProt →
Function. Transcription factor expressed after fertilization required for zygotic genome activation (ZGA), a critical event in early embryonic development during which the developmental control passes from maternally provided mRNAs to the expression of the zygotic genome after fertilization. Binds and activates expression of key ZGA marker genes, such as NANOGNB, ZSCAN4, DUXB, KLF5 and DPPA3. Binds to regulatory DNA sequences containing a 5’-TAATCC-3’ sequence motif.
Subcellular location. Nucleus.
Similarity. Belongs to the paired homeobox family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q8N7U7-1 | 1 | yes |
| Q8N7U7-2 | 2 |
RefSeq proteins (2): NP_001384275, NP_940881 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001356 | HD | Domain |
| IPR009057 | Homeodomain-like_sf | Homologous_superfamily |
UniProt features (17 total): compositionally biased region 7, region of interest 4, sequence conflict 3, chain 1, DNA-binding region 1, splice variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8N7U7-F1 | 47.45 | 0.04 |
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-9819196 | Zygotic genome activation (ZGA) |
MSigDB gene sets: 24 (showing top):
GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, GLI1_TARGET_GENES, ZNF146_TARGET_GENES, ZNF486_TARGET_GENES, MIR607, MIR4262, MIR3671, MIR181A_5P_MIR181B_5P, MIR181D_5P, MIR181C_5P, MIR1252_5P, MIR3123, MIR12128, MIR1226_3P, MIR3936
GO Biological Process (3): maternal-to-zygotic transition of gene expression (GO:0160021), regulation of DNA-templated transcription (GO:0006355), regulation of transcription by RNA polymerase II (GO:0006357)
GO Molecular Function (2): DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), DNA binding (GO:0003677)
GO Cellular Component (3): chromatin (GO:0000785), nucleoplasm (GO:0005654), nucleus (GO:0005634)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| Maternal to zygotic transition (MZT) | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| regulation of gene expression | 2 |
| cellular anatomical structure | 2 |
| DNA-templated transcription | 1 |
| regulation of RNA biosynthetic process | 1 |
| regulation of DNA-templated transcription | 1 |
| transcription by RNA polymerase II | 1 |
| chromatin | 1 |
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 1 |
| DNA-binding transcription factor activity | 1 |
| regulation of transcription by RNA polymerase II | 1 |
| nucleic acid binding | 1 |
| chromosome | 1 |
| nuclear lumen | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
408 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| TPRX1 | CRX | O43186 | 879 |
| TPRX1 | DPRX | A6NFQ7 | 818 |
| TPRX1 | ARGFX | A6NJG6 | 797 |
| TPRX1 | DUXB | A0A1W2PPF3 | 768 |
| TPRX1 | LEUTX | A8MZ59 | 729 |
| TPRX1 | DUXA | A6NLW8 | 705 |
| TPRX1 | NANOGNB | Q7Z5D8 | 667 |
| TPRX1 | RHOXF2B | P0C7M4 | 570 |
| TPRX1 | LBX1 | P52954 | 527 |
| TPRX1 | ANHX | E9PGG2 | 463 |
| TPRX1 | RHOXF2 | Q9BQY4 | 419 |
| TPRX1 | DUX4L2 | P0CJ85 | 409 |
| TPRX1 | ZMAT1 | Q5H9K5 | 408 |
| TPRX1 | UNCX | A6NJT0 | 404 |
| TPRX1 | DRGX | A6NNA5 | 403 |
IntAct
2 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| TPRX1 | PARP4 | psi-mi:“MI:0915”(physical association) | 0.400 |
BioGRID (20): TPRX1 (Two-hybrid), TPRX1 (Two-hybrid), TPRX1 (Two-hybrid), TPRX1 (Two-hybrid), TPRX1 (Two-hybrid), TPRX1 (Two-hybrid), MKRN3 (Two-hybrid), KRTAP6-2 (Two-hybrid), NELFB (Two-hybrid), INCA1 (Two-hybrid), GOLGA6L9 (Two-hybrid), PRR20B (Two-hybrid), PRR20A (Two-hybrid), FANCG (Two-hybrid), PRR20D (Two-hybrid)
ESM2 similar proteins: A0A0J9YWL9, A0A0J9YY54, A0A0U1RQI7, A0A494C071, A6NNC1, A6QL64, B3KS81, D3YZV8, E2RYF7, E9Q6E9, F1LWT0, F8W0I5, O60732, P0C8Z4, P0DKJ7, P0DKJ8, P0DKL2, P0DPF3, P18751, P20930, P43537, P53353, P59797, P62521, Q01456, Q08AG5, Q12816, Q3BBV2, Q5H9R4, Q5HY64, Q5JPF3, Q6P902, Q6ZQX7, Q86T75, Q86VE3, Q86VQ3, Q8BGJ3, Q8N307, Q8N7U7, Q8N7X1
Diamond homologs: A1YEV8, A1YEY5, A1YFI3, A1YG25, A1YG57, A1YGA2, A2T711, A2T733, A2T777, A2T7P4, A6YP92, F1NEA7, G3X9P6, G3X9U1, O14813, O15499, O35085, O35160, O42115, O43186, O43316, O54751, O73592, O75364, O93385, O97670, P06601, P09082, P09083, P0DV77, P10181, P18264, P20270, P21711, P22810, P29454, P32242, P32243, P50223, P53544
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
96 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 77 |
| Likely benign | 19 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
571 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 19:47802978:CAC:C | acceptor_gain | 1.0000 |
| 19:47803498:TCAGA:T | donor_loss | 1.0000 |
| 19:47803499:CAGA:C | donor_loss | 1.0000 |
| 19:47803500:AGAC:A | donor_loss | 1.0000 |
| 19:47803501:GAC:G | donor_loss | 1.0000 |
| 19:47803502:AC:A | donor_loss | 1.0000 |
| 19:47803503:C:CT | donor_loss | 1.0000 |
| 19:47803518:C:CA | donor_gain | 1.0000 |
| 19:47803670:GGGC:G | acceptor_gain | 1.0000 |
| 19:47803671:GGC:G | acceptor_gain | 1.0000 |
| 19:47803672:GC:G | acceptor_gain | 1.0000 |
| 19:47803673:CC:C | acceptor_gain | 1.0000 |
| 19:47803674:C:CC | acceptor_gain | 1.0000 |
| 19:47803674:CTGG:C | acceptor_loss | 1.0000 |
| 19:47803675:T:C | acceptor_loss | 1.0000 |
| 19:47802976:CACAC:C | acceptor_gain | 0.9900 |
| 19:47802977:ACAC:A | acceptor_gain | 0.9900 |
| 19:47802978:CACC:C | acceptor_gain | 0.9900 |
| 19:47802982:T:C | acceptor_loss | 0.9900 |
| 19:47802989:C:CT | acceptor_gain | 0.9900 |
| 19:47802990:A:T | acceptor_gain | 0.9900 |
| 19:47803506:G:A | donor_gain | 0.9900 |
| 19:47803509:G:C | donor_gain | 0.9900 |
| 19:47803669:AGGGC:A | acceptor_gain | 0.9900 |
| 19:47803680:G:C | acceptor_gain | 0.9900 |
| 19:47803680:G:GC | acceptor_gain | 0.9900 |
| 19:47818967:CTCAC:C | donor_loss | 0.9900 |
| 19:47818968:TCAC:T | donor_loss | 0.9900 |
| 19:47818969:CACCT:C | donor_loss | 0.9900 |
| 19:47818970:A:C | donor_loss | 0.9900 |
AlphaMissense
2909 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 19:47802969:C:A | K14N | 0.985 |
| 19:47802969:C:G | K14N | 0.985 |
| 19:47803508:A:G | L9P | 0.957 |
| 19:47802964:C:G | R16P | 0.955 |
| 19:47802970:T:A | K14M | 0.955 |
| 19:47802972:G:C | F13L | 0.955 |
| 19:47802972:G:T | F13L | 0.955 |
| 19:47802974:A:G | F13L | 0.955 |
| 19:47802975:C:A | W12C | 0.953 |
| 19:47802975:C:G | W12C | 0.953 |
| 19:47802973:A:G | F13S | 0.950 |
| 19:47802977:A:G | W12R | 0.948 |
| 19:47802977:A:T | W12R | 0.948 |
| 19:47803517:T:A | E6V | 0.946 |
| 19:47802965:G:T | R16S | 0.939 |
| 19:47802959:C:G | A18P | 0.933 |
| 19:47802954:T:A | K19N | 0.926 |
| 19:47802954:T:G | K19N | 0.926 |
| 19:47802968:T:C | N15D | 0.923 |
| 19:47802970:T:G | K14T | 0.923 |
| 19:47802967:T:C | N15S | 0.921 |
| 19:47802962:G:T | R17S | 0.917 |
| 19:47803518:C:T | E6K | 0.911 |
| 19:47802967:T:G | N15T | 0.908 |
| 19:47802967:T:A | N15I | 0.906 |
| 19:47802971:T:C | K14E | 0.906 |
| 19:47802961:C:G | R17P | 0.903 |
| 19:47802966:A:C | N15K | 0.900 |
| 19:47802966:A:T | N15K | 0.900 |
| 19:47802980:C:T | V11M | 0.876 |
dbSNP variants (sampled 300 via entrez): RS1000067162 (19:47814000 A>C), RS1000241886 (19:47808271 T>C), RS1000299028 (19:47820997 C>A,T), RS1000574795 (19:47817930 C>T), RS1000645890 (19:47819154 T>G), RS1000777598 (19:47801393 A>G), RS1000862751 (19:47805122 A>G), RS1001025614 (19:47810677 T>G), RS1001037778 (19:47816213 C>T), RS1001088667 (19:47816033 C>T), RS1001149556 (19:47803036 T>A,G), RS1001268673 (19:47809515 T>C), RS1001280507 (19:47813225 G>A), RS1001331956 (19:47810873 G>A,C), RS1001361224 (19:47818927 T>A)
Disease associations
OMIM: gene MIM:611166 | disease phenotypes: MIM:120970
GenCC curated gene-disease
Mondo (1): cone-rod dystrophy 2 (MONDO:0007362)
Orphanet (1): Cone rod dystrophy (Orphanet:1872)
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
3 total (human), top 3 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| aristolochic acid I | increases expression | 1 |
| tris(1,3-dichloro-2-propyl)phosphate | increases expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): cone-rod dystrophy 2